Ads
related to: prostate specific antigen in women over 70 percent range- PsA Treatment Options
Exploring A Treatment Plan Change?
See Additional Treatment Options.
- See Treatment Results
Help Manage Your PsA Symptoms
With A Pill Option.
- Find A Rheumatologist
Find A Rheumatologist Near You.
Set Goals For PsA Treatment.
- Learn About This Option
Still Experiencing PsA Symptoms?
A Change In Treatment Can Help.
- PsA Treatment Options
Search results
Results From The WOW.Com Content Network
Prostate-specific antigen (PSA), also known as gamma-seminoprotein or kallikrein-3 (KLK3), P-30 antigen, is a glycoprotein enzyme encoded in humans by the KLK3 gene. PSA is a member of the kallikrein -related peptidase family and is secreted by the epithelial cells of the prostate gland in men and the paraurethral glands in women.
Carcinoembryonic antigen (CEA) Non-smokers, 50 years: 3.4, [5] 3.6 [73] μg/L: Non-smokers, 70 years: 4.1 [73] Smokers: 5 [74] Prostate specific antigen (PSA) 40–49 years: 1.2–2.9 [75] μg/L [5] [15] or ng/mL [23] More detailed cutoffs in PSA – Serum levels: 70–79 years, non-African-American: 4.0–9.0 [75] 70–79 years, African ...
Prostate-specific antigen. Prostate-specific antigen (PSA) is secreted by the epithelial cells of the prostate gland and can be detected in a sample of blood. [14] PSA is present in small quantities in the serum of men with healthy prostates, but is often elevated in the presence of prostate cancer or other prostate disorders. [15]
Prostate cancer staging is the process by which physicians categorize the risk of cancer having spread beyond the prostate, or equivalently, the probability of being cured with local therapies such as surgery or radiation. Once patients are placed in prognostic categories, this information can contribute to the selection of an optimal approach ...
In some prostate cancers, PSMA is the second-most upregulated gene product, with an 8- to 12-fold increase over levels in noncancerous prostate cells. [19] Because of this high expression, PSMA is being developed as potential biomarker for therapy and imaging of some cancers. [ 20 ]
Semenogelase (EC 3.4.21.77, prostate-specific antigen, alpha-seminoprotein, seminin, P-30 antigen, antigen (human clone HPSA-1 prostate-specific protein moiety reduced), gamma-seminoglycoprotein (human protein moiety reduced), gamma-SM, antigen PSA (human prostate-specific), human glandular kallikrein, antigen PSA (human clone 5P1 protein moiety reduced)) is an enzyme.
Ads
related to: prostate specific antigen in women over 70 percent range